VA SB1084 | 2023 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 9 2023 - 25% progression, died in chamber
Action: 2023-01-26 - Stricken at request of patron in Education and Health (14-Y 0-N)
Text: Latest bill text (Prefiled) [HTML]
Status: Introduced on January 9 2023 - 25% progression, died in chamber
Action: 2023-01-26 - Stricken at request of patron in Education and Health (14-Y 0-N)
Text: Latest bill text (Prefiled) [HTML]
Summary
Prescription of Schedule VI controlled substances; asynchronous interactions; report. Allows practitioners to establish a bona fide practitioner-patient relationship through asynchronous interaction for the purpose of prescribing Schedule VI controlled substances if the patient chooses not to use insurance for the encounter and if such prescribing complies with federal requirements for the practice of telemedicine. The bill directs the Board of Pharmacy to conduct a review of Schedule VI controlled substances and report to the Chairmen of the Senate Committee on Education and Health and the House Committee on Health, Welfare and Institutions by December 31, 2023, any Schedule VI substances that the General Assembly may want to consider rescheduling due to potential risk of abuse by a patient if prescribed in accordance with the standard of care for asynchronous telemedicine interactions. Prescription of Schedule VI controlled substances; asynchronous interactions; report. Allows practitioners to establish a bona fide practitioner-patient relationship through asynchronous interaction for the purpose of prescribing Schedule VI controlled substances if the patient chooses not to use insurance for the encounter and if such prescribing complies with federal requirements for the practice of telemedicine. The bill directs the Board of Pharmacy to conduct a review of Schedule VI controlled substances and report to the Chairmen of the Senate Committee on Education and Health and the House Committee on Health, Welfare and Institutions by December 31, 2023, any Schedule VI substances that the General Assembly may want to consider rescheduling due to potential risk of abuse by a patient if prescribed in accordance with the standard of care for asynchronous telemedicine interactions.
Title
Prescription of Schedule VI controlled substances; asynchronous interactions.
Sponsors
Sen. John Bell [D] |
Roll Calls
2023-01-26 - Senate - Senate: Stricken at request of patron in Education and Health (14-Y 0-N) (Y: 14 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-01-26 | Senate | Stricken at request of patron in Education and Health (14-Y 0-N) |
2023-01-11 | Senate | Assigned Education sub: Health Professions |
2023-01-09 | Senate | Referred to Committee on Education and Health |
2023-01-09 | Senate | Prefiled and ordered printed; offered 01/11/23 23104083D |